Telomir Pharmaceuticals, Inc. is a pharmaceutical firm in pre-clinical stages, concentrating on Telomir-1's development and marketing. Telomir-1 is a pioneering small molecule designed to extend telomere caps, protecting DNA and potentially reversing age-related ailments. Telomeres, composed of DNA and proteins, safeguard chromosome ends. Aging leads to telomere shortening, accelerated by metal reactivity, heightening vulnerab...
Telomir Pharmaceuticals, Inc. is a pharmaceutical firm in pre-clinical stages, concentrating on Telomir-1's development and marketing. Telomir-1 is a pioneering small molecule designed to extend telomere caps, protecting DNA and potentially reversing age-related ailments. Telomeres, composed of DNA and proteins, safeguard chromosome ends. Aging leads to telomere shortening, accelerated by metal reactivity, heightening vulnerability to degenerative diseases. Telomir aims to launch Telomir-1 orally for hemochromatosis and eventually for post-chemotherapy recovery and various age-related inflammatory conditions like osteoarthritis.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.